embla ApS: Financial statements 2023
CVR: 42806366
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
embla ApS (CVR 42806366) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -4,613,567 and a net result of DKK -27,506,127. Equity in the 2023 report amounted to DKK 61,212,761. The solvency ratio was 91.1%. The company had 38 employees in the financial year.
- Gross Profit
- DKK -4,613,567
- Profit/Loss
- DKK -27,506,127
- Equity
- DKK 61,212,761
- Total Assets
- DKK 67,174,723
- Employees
- 38
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of October 31, 2023, Ulla Brockenhuus-Schack has joined the board of directors of embla ApS.
As of October 31, 2023, Niels Vejrup Carlsen has left the board of directors of embla ApS.
Embla ApS has published its interim report for the period November 3, 2021 – December 31, 2022.
As of July 6, 2023, Niels Vejrup Carlsen has joined the board of directors of embla ApS.
As of July 6, 2023, Krzysztof Jan Przybylak has joined the board of directors of embla ApS.
About embla ApS
embla ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2021. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named XYZhealth ApS. The management consists of Laust Wilster Axelsen and Nicholas Syhler. The board consists of Laust Wilster Axelsen (chair), Hekla Arnardóttir, Nicholas Syhler and Ulla Brockenhuus-Schack. The company's owners include FOUNDERS A/S, Syhler Consulting ApS and Seed Capital Denmark IV K/S. According to the 2025 annual report, the company had an average of 20 employees. In 2025, the company reported a gross profit of DKK 2,698,114 and a net result of DKK -40,739,523 compared with DKK -16,824,952 the year before. Equity in the 2025 report amounted to DKK 3,648,749.